Labcorp (LH) EVP converts 376 RSUs and withholds 99 shares for taxes

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Sandra D. van der Vaart reported equity award activity and related tax withholding. On February 11, 2026, she exercised 376 Restricted Stock Units, converting them into 376 shares of common stock at an exercise price of $0 per share.

After this conversion, her directly held common stock position was 3,225.4864 shares before tax withholding. To cover tax obligations, 99 shares of common stock were withheld at a price of $289.89 per share, leaving 3,126.4864 shares of common stock held directly. Following the transaction, she also held 1,141 Restricted Stock Units, each representing the right to receive one common share as they vest in three equal annual installments beginning on February 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van der Vaart Sandra D

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Affairs

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		376	A	(1)	3,225.4864	D
Common Stock	02/11/2026		F(2)		99	D	$289.89	3,126.4864	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			376	(3)	(3)	Common Stock	376	$0	1,141(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Sandra D. van der Vaart	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LH executive Sandra D. van der Vaart report?

Sandra D. van der Vaart reported exercising 376 Restricted Stock Units into 376 shares of Labcorp common stock on February 11, 2026. The derivative exercise was priced at $0 per share and increased her directly held common stock before related tax withholding.

How many Labcorp (LH) shares were withheld for taxes in this Form 4?

To satisfy tax withholding obligations, 99 shares of Labcorp common stock were withheld at a price of $289.89 per share. This reduced Sandra D. van der Vaart’s directly held common stock balance from 3,225.4864 shares to 3,126.4864 shares after the withholding.

How many Labcorp (LH) common shares does Sandra D. van der Vaart hold after the reported transactions?

After the February 11, 2026 transactions, Sandra D. van der Vaart directly holds 3,126.4864 shares of Labcorp common stock. This figure reflects both the 376-share RSU conversion and the subsequent withholding of 99 shares to cover tax obligations associated with the award.

What Restricted Stock Unit holdings does the LH executive report on this Form 4?

Following the reported activity, Sandra D. van der Vaart holds 1,141 Restricted Stock Units. Each RSU represents the contingent right to receive one share of Labcorp common stock as the grant vests over three equal annual installments beginning February 11, 2026.

How do the Labcorp (LH) RSUs vest for Sandra D. van der Vaart?

The Restricted Stock Units vest in three equal annual installments starting on February 11, 2026. As each installment vests, the corresponding RSUs convert into Labcorp common stock on a one-for-one basis, subject to applicable tax withholding obligations at the time of settlement.

What do the transaction codes M and F mean in this Labcorp (LH) Form 4?

Code M reflects the exercise or conversion of a derivative security, here the RSUs converting into 376 common shares at $0 per share. Code F represents a tax-withholding disposition, where 99 shares were withheld to pay tax obligations rather than sold in an open-market trade.